Chiral Switches of Tramadol Hydrochloride, a Potential Psychedelic Drug-Past and Future
- PMID: 39291005
- PMCID: PMC11403737
- DOI: 10.1021/acsmedchemlett.4c00322
Chiral Switches of Tramadol Hydrochloride, a Potential Psychedelic Drug-Past and Future
Abstract
The chiral opioid analgesic tramadol was patented (1962) as a cis- and trans-racemates mixture. A first chiral switch led to the (±)-cis-(1RS,2RS) racemate, patented and approved as Tramal (1980), preferred over the (+)-cis-(1R,2R)-enantiomer. Consecutive chiral switches of (±)-cis-tramadol to (+)-cis-(1R,2R)-tramadol/salts were patented. This Viewpoint calls for developing (+)-cis-(1R,2R)-tramadol medicines and recognizing tramadol medicines as potential psychedelics to overcome the spreading tramadol crisis.
© 2024 American Chemical Society.
Conflict of interest statement
The authors declare no competing financial interest.
Figures
References
-
- Organic Stereochemistry: Guiding Principles and Biomedicinal Relevance. Testa B.; Caldwell J.; Kisakürek M. V. Eds., VHCA Zurich and Wiley-VCH: Weinheim; 2014; pp I–XVI, 1–408.
-
- The Opioid Crisis and Recent Federal Policy Responses. Congressional Budget Office, September 28, 2022. https://www.cbo.gov/publication/58221 (accessed July 1, 2024).
-
- Scheck J.Tramadol: The Opioid Crisis for the Rest of the World. The Wall Street Journal, Oct 19, 2016.
-
- United Nations Office on Drugs and Crimes (UNODC) . World Drug Report 2018; United Nations; publication, Sales No. E.18.XI.9.
LinkOut - more resources
Full Text Sources
Miscellaneous
